Dr. Durgam is a CNS drug-development executive with more than two decades of experience spanning clinical development, medical affairs, regulatory strategy and pharmacovigilance. Most recently, he served as Executive Vice President and Chief Medical Officer of Intra-Cellular Therapies, Inc. (“Intra-Cellular”), where he provided strategic oversight across global clinical development and operations, data science, regulatory affairs, drug safety and medical affairs. Intra-Cellular was acquired by Johnson & Johnson in April 2025.
Read the full press release below:
About Bedford Group Transearch
Founded in 1979, Bedford Group Transearch is one of North America’s leading privately held executive search firms, recognized for its deep expertise in the Life Sciences. With offices across Canada and the United States, Bedford partners with organizations ranging from innovative startups to global multinationals. The firm’s Life Sciences practice spans Pharmaceuticals, Biotechnology, Clinical Research, Pharmacy, and MedTech, helping clients build world-class executive leadership teams equipped to drive growth and innovation.
Learn more at www.bedfordgroup.com/healthcare
